From the Faculty of Medicine and Dentistry.
Division of Rheumatology, University of Alberta, Edmonton, Alberta, Canada.
J Clin Rheumatol. 2022 Aug 1;28(5):240-244. doi: 10.1097/RHU.0000000000001841. Epub 2022 Apr 28.
Patients are increasingly turning to the Internet for health guidance, requiring awareness from clinicians of constantly changing resources and quality of available information. A previous study demonstrated a minority of YouTube videos were useful for teaching methotrexate (MTX) self-injection; however, YouTube content constantly evolves, and previous results may not represent current videos. This study provides an update on previous work from 2014 evaluating the quality of YouTube videos demonstrating self-administered subcutaneous MTX injections. Our aim was to evaluate how YouTube videos on MTX injection have changed and evaluate the current video quality.
"Methotrexate injection" was searched on YouTube. The first 75 videos were analyzed independently by 2 reviewers. Videos were classified as useful, misleading/irrelevant, or a personal patient view and rated for reliability, comprehensiveness, and quality.
Of the 75 videos reviewed, 12 were classified as useful (16%), 43 misleading/irrelevant (57.3%), and 20 personal patient views (26.7%). Although this represents a substantial increase from previous results in the proportion of videos deemed misleading/irrelevant (57.3% vs. 27.5%) ( p = 0.0011), their reliability and global quality scores were higher.
Concordant with the previous study, only a small proportion of the total videos were deemed useful videos for MTX injection specifically. However, reliability and global quality scores for all videos increased from the previous study, suggesting more videos provide reliable information with regard to MTX overall, even if it does not speak to self-injection directly. Logistics of the YouTube algorithm may still impede access to the "best" videos for patient teaching; therefore, clinicians should be prepared to recommend strategies for patients to find high-quality videos.
患者越来越多地在互联网上寻求健康指导,这要求临床医生了解不断变化的资源和可用信息的质量。之前的一项研究表明,YouTube 上的少数视频对教授甲氨蝶呤(MTX)自注有用;然而,YouTube 上的内容不断演变,以前的结果可能无法代表当前的视频。本研究对 2014 年评估演示 MTX 皮下自我注射的 YouTube 视频质量的先前工作进行了更新。我们的目的是评估 MTX 注射的 YouTube 视频如何发生变化,并评估当前视频的质量。
在 YouTube 上搜索“MTX 注射”。由两名审查员独立分析前 75 个视频。将视频分为有用、误导/不相关和个人患者观点,并对可靠性、全面性和质量进行评分。
在审查的 75 个视频中,有 12 个被归类为有用(16%),43 个被归类为误导/不相关(57.3%),20 个被归类为个人患者观点(26.7%)。尽管这代表了以前结果中被认为是误导/不相关的视频比例(57.3%比 27.5%)(p=0.0011)有了实质性的增加,但它们的可靠性和整体质量评分更高。
与之前的研究一致,只有一小部分视频被认为是专门用于 MTX 注射的有用视频。然而,与之前的研究相比,所有视频的可靠性和整体质量评分都有所提高,这表明即使视频不直接涉及自我注射,也有更多的视频提供有关 MTX 的可靠信息。YouTube 算法的逻辑可能仍然会阻碍患者教学的“最佳”视频的获取;因此,临床医生应该准备好为患者推荐寻找高质量视频的策略。